Analysts Give Privia Health Group, an Average Rating of “Buy”

🌥️Trending News

Privia Health ($NASDAQ:PRVA) Group, Inc. has recently been given an average rating of “Buy” by analysts. The company is a technology-enabled healthcare services organization that works to transform healthcare delivery, drive physician alignment and improve population health. Privia Health offers a comprehensive suite of services including population health management, physician practice optimization, and ambulatory care transformation to help physicians better serve their patients and communities. The company’s innovative technology solutions allow physicians to be more efficient, engage patients in their own care, and improve overall health outcomes. Privia Health is also focused on delivering cost savings for healthcare systems through its outcomes-based approach.

The company also provides services such as strategic guidance for IT investments, practice operations consulting, and patient engagement services. With the help of its technology solutions and services, Privia Health has helped numerous healthcare organizations in improving the quality of care, reducing costs, and providing better access to care. Analysts have noted that Privia Health’s service offerings are well-positioned to benefit from the current shift toward value-based care. With its ability to deliver operational efficiencies and cost savings, Privia Health could be a great long-term investment opportunity for investors.

Share Price

PRIVIA HEALTH opened at $23.3 and closed at $22.9, showing a 0.8% decrease from the prior closing price of $23.0. This small dip was not enough to deter analysts from continuing to suggest a “Buy” rating on the company’s stock, as they believe that the company is likely to experience future growth. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Privia Health. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Privia Health. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Privia Health. More…

Key Ratios Snapshot

Some of the financial key ratios for Privia Health are shown below. More…

Analysis

At GoodWhale, we conducted an analysis of PRIVIA HEALTH‘s fundamentals to better understand the company. According to our Star Chart, PRIVIA HEALTH is strong in asset, growth, and medium in profitability, but weak in dividend. We classify PRIVIA HEALTH as a ‘cheetah’, a type of company that achieves high revenue or earnings growth but is considered less stable due to lower profitability. Given the above assessment, we believe that investors who are looking for higher-than-average returns with a higher risk should consider investing in PRIVIA HEALTH. It has a high health score of 10/10 with regard to its cash flows and debt, indicating that it is capable of paying off debt and funding future operations. Moreover, given its strong growth rate, it may offer attractive returns for investors that are comfortable with the risk of the higher volatility associated with such a company. More…

Peers

Privia Health Group Inc is one of the leading players in the healthcare industry, competing against PreAxia Health Care Payment Systems Inc, Livecare Inc, and Evolent Health Inc, among others. These companies all strive to provide the best healthcare services and solutions for their customers, driving innovation in the industry and pushing each other to be better. As such, competition between Privia and its competitors has become increasingly fierce over the years.

– PreAxia Health Care Payment Systems Inc ($OTCPK:PAXH)

Axia Health Care Payment Systems Inc is a leading healthcare payments processor, providing a comprehensive suite of solutions to help providers streamline the revenue cycle management process. With a market capitalization of 1.12 million as of 2022, the company is well-positioned to continue its growth trajectory in the healthcare payments space. Additionally, Axia’s Return on Equity (ROE) of 5.11% provides investors with a solid return on their investment. The company’s solutions help reduce administrative costs, minimize fraud and compliance risks, and track payments across multiple channels. Axia’s payment solutions are used by thousands of providers, health plans, and other healthcare organizations around the world.

– Livecare Inc ($OTCPK:LVCE)

Evolent Health Inc is a health care technology company that provides services to providers and health plans in the United States. The company has a market cap of 2.79B as of 2022, making it one of the largest publicly traded companies in the healthcare industry. The company has a negative return on equity of -3.43%, indicating that it is not able to generate a consistent return from its assets and investments. This suggests that the company is not maximizing its potential earnings and overall shareholder value. Evolent Health Inc is focused on transforming the healthcare delivery system by providing innovative technology, analytics, and consulting solutions to providers, health plans, and other stakeholders.

Summary

Analysts have given Privia Health Group, Inc. an average rating of “Buy”, suggesting the stock is a good investment. Investors should consider the company’s strong financials and the potential for growth in the healthcare industry. Privia Health’s unique value proposition of cultivating relationships with providers, focus on patient-centric care and integrated technology platforms makes it an attractive option. The company’s recent partnerships with Humana and Blue Cross Blue Shield of Louisiana demonstrate the potential for growth in the medical-managed care sector.

Additionally, analysts have noted that Privia Health’s strong balance sheet and focus on reducing healthcare costs make it a worthwhile investment. With an encouraging outlook across industry sectors, investors would do well to consider Privia Health Group, Inc. when making decisions about their investments.